Roctavian Educational Program

Join the Western PA Bleeding Disorders Foundation and representatives from BioMarin to dive into the gene therapy treatment advancements for Hemophilia A.

This education program offers you the opportunity to:

• Learn about Roctavian, the first and only FDA approved gene therapy for Hemophilia A
• Gain valuable information and deepen your understanding of Roctavian through a live Q&A session
• Ask questions and receive new resources on gene therapy

To register, send an email to rsvp@wpbdf.org or call 724-741-6160. Please be sure to include the number of people you are registering for and any food restrictions we should be aware of.

Medical Disclaimer: WPBDF does not give medical advice or engage in the practice of medicine. WPBDF under no circumstances recommends treatment for specific individuals and in all cases recommends that you consult your physician or local hemophilia treatment center before pursuing any course of treatment.

Click here for more information on Roctavian.